About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 697036, 9 pages
http://dx.doi.org/10.1155/2011/697036
Review Article

A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides

1Proteomics Unit, IRCCS “Centro S. Giovanni di Dio-FBF”, 25125 Brescia, Italy
2NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, 25125 Brescia, Italy
3Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden
4IRCCS San Camillo, Lido VE, 30126 Venice, Italy

Received 1 June 2011; Revised 27 June 2011; Accepted 30 June 2011

Academic Editor: Thomas Van Groen

Copyright © 2011 Roberta Ghidoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Mirko Bibl, Marion Gallus, Volker Welge, Hermann Esselmann, Stefanie Wolf, Eckart Ruether, and Jens Wiltfang, “Cerebrospinal fluid amyloid-beta 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia,” Journal Of Neural Transmission, vol. 119, no. 7, pp. 805–813, 2012. View at Publisher · View at Google Scholar
  • Mirko Bibl, Marion Gallus, Volker Welge, Sabine Lehmann, Katrin Sparbier, Hermann Esselmann, and Jens Wiltfang, “Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides,” PROTEOMICS - Clinical Applications, vol. 6, no. 3-4, pp. 163–169, 2012. View at Publisher · View at Google Scholar
  • Giuseppe Di Fede, Marcella Catania, Michela Morbin, Giorgio Giaccone, Maria Luisa Moro, Roberta Ghidoni, Laura Colombo, Massimo Messa, Alfredo Cagnotto, Margherita Romeo, Matteo Stravalaci, Luisa Diomede, Marco Gobbi, Mario Salmona, and Fabrizio Tagliavini, “Good gene, bad gene: New APP variant may be both,” Progress in Neurobiology, vol. 99, no. 3, pp. 281–292, 2012. View at Publisher · View at Google Scholar
  • Giuliano Binetti, Giovanni B. Frisoni, Roberta Ghidoni, Valentina Albertini, Luisa Benussi, Anna Paterlini, Michela Glionna, Annapaola Prestia, Luisella Bocchio-Chiavetto, Giovanni Amicucci, Samantha Galluzzi, Andrea Adorni, and Cristina Geroldi, “Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia,” Electrophoresis, vol. 33, no. 24, pp. 3738–3744, 2012. View at Publisher · View at Google Scholar
  • Dominic Holland, Linda K. McEvoy, Rahul S. Desikan, and Anders M. Dale, “Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials,” Plos One, vol. 7, no. 10, 2012. View at Publisher · View at Google Scholar
  • Mirko Bibl, Marion Gallus, Volker Welge, Hermann Esselmann, and Jens Wiltfang, “Aminoterminally Truncated and Oxidized Amyloid-beta Peptides in the Cerebrospinal Fluid of Alzheimer's Disease Patients,” Journal Of Alzheimers Disease, vol. 29, no. 4, pp. 809–816, 2012. View at Publisher · View at Google Scholar
  • Roberta Ghidoni, Anna Paterlini, and Luisa Benussi, “Translational proteomics in Alzheimer's disease and related disorders,” Clinical Biochemistry, vol. 46, no. 6, pp. 480–486, 2013. View at Publisher · View at Google Scholar
  • Samantha Galluzzi, Orazio Zanetti, Giovanni B. Frisoni, Cristina Geroldi, Giovanni Amicucci, Luisella Bocchio-Chiavetto, Matteo Bonetti, Cristian Bonvicini, Maria Cotelli, Roberta Ghidoni, and Barbara Paghera, “Supporting evidence for using biomarkers in the diagnosis of MCI due to AD,” Journal of Neurology, vol. 260, no. 2, pp. 640–650, 2013. View at Publisher · View at Google Scholar
  • Vasileios T. Papaliagkas, “The role of cerebrospinal fluid biomarkers for alzheimer's disease diagnosis. where are we now?,” Recent Patents on CNS Drug Discovery, vol. 8, no. 1, pp. 70–78, 2013. View at Publisher · View at Google Scholar